Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
2020 ◽
Vol 18
◽
pp. 415-421
◽
2010 ◽
pp. 21-37
◽
2012 ◽
Vol 53
(2)
◽
pp. 217-222
◽
2010 ◽
pp. 179-196
◽